CoreCap Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Sell
60
-14
-19% -$2.08K ﹤0.01% 2023
2026
Q1
$6.89K Sell
74
-77
-51% -$6.82K ﹤0.01% 2092
2025
Q4
$12.1K Buy
151
+127
+529% +$10.6K ﹤0.01% 1888
2025
Q3
$2.34K Hold
24
﹤0.01% 2352
2025
Q2
$1.67K Hold
24
﹤0.01% 2343
2025
Q1
$1.19K Sell
24
-6
-20% -$379 ﹤0.01% 2487
2024
Q4
$2.1K Buy
30
+6
+25% +$498 ﹤0.01% 2218
2024
Q3
$2.52K Buy
+24
New +$2.81K ﹤0.01% 2143
2024
Q2
Sell
-338
Closed -$37.7K 1612
2024
Q1
$37.7K Sell
338
-2,168
-87% -$258K ﹤0.01% 1223
2023
Q4
$325K Buy
+2,506
New +$345K 0.02% 429

Other funds holding ACLS

CoreCap Advisors's ACLS Position: Q2 2026 in Review

CoreCap Advisors reduced its Axcelis (ACLS) stake by 19% in Q2 2026, selling an estimated $2.08K and leaving 60 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2023.

CoreCap Advisors first reported a position in ACLS in Q4 2023 and has held it in 10 quarters since. The position peaked at $325K in Q4 2023. 40 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • CoreCap Advisors held 60 shares of Axcelis worth $11.4K as of Q2 2026.
  • CoreCap Advisors sold 14 Axcelis shares in Q2 2026, an estimated $2.08K.
  • Axcelis made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2023 holding.
  • CoreCap Advisors first reported a position in Axcelis in Q4 2023 and has held it in 10 quarters since.
  • CoreCap Advisors's Axcelis position peaked at $325K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.